Home Vaccinex

Vaccinex

In operation
IPO
Targeted Biologic Therapies Developer
Basic
Enterprise Profile
LinkedIn

Basic Information

Vaccinex, Inc. is a clinical-stage immunotherapy company engaged in the discovery and development of targeted biotherapies to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative disorders, and autoimmune diseases, currently undergoing active clinical trials in non-small-scale clinical studies.
Vaccinex, Inc.
NewYork,United States of America
15~50 people
January 01, 1997
info@vaccinex.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Biological Pharmaceutical Products
Technology
Gene Technology Targeted Technology Immunological Techniques Cell Technology
Concept
Tumor Immune System Diseases # Nervous System Diseases Therapeutic Products
Application Scenarios
Biologics Innovative Drugs